Literature DB >> 20300968

A contemporary update on scleroderma.

Loïc Guillevin.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 20300968     DOI： 10.1007/s12016-010-8200-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   8.667


× No keyword cloud information.
  74 in total

Review 1.  Ubiquitination system and autoimmunity: the bridge towards the modulation of the immune response.

Authors:  Diana Gómez-Martín; Mariana Díaz-Zamudio; Jorge Alcocer-Varela
Journal:  Autoimmun Rev       Date:  2008-01-07       Impact factor: 9.754

Review 2.  Mechanisms of T regulatory cell function.

Authors:  Nadir Askenasy; Ayelet Kaminitz; Shai Yarkoni
Journal:  Autoimmun Rev       Date:  2008-03-24       Impact factor: 9.754

3.  Time to diagnosis in systemic sclerosis: is sex a factor?

Authors:  Marie Hudson; Brett Thombs; Murray Baron
Journal:  Arthritis Rheum       Date:  2009-02-15

4.  Prevalence and clinical correlates of pruritus in patients with systemic sclerosis.

Authors:  Ilya Razykov; Brett D Thombs; Marie Hudson; Marielle Bassel; Murray Baron
Journal:  Arthritis Rheum       Date:  2009-12-15

Review 5.  Definition of human autoimmunity--autoantibodies versus autoimmune disease.

Authors:  Ana Lleo; Pietro Invernizzi; Bin Gao; Mauro Podda; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2009-12-04       Impact factor: 9.754

6.  Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.

Authors:  Stephen C Mathai; Laura K Hummers; Hunter C Champion; Fredrick M Wigley; Ari Zaiman; Paul M Hassoun; Reda E Girgis
Journal:  Arthritis Rheum       Date:  2009-02

Review 7.  Infections as triggers and complications of systemic lupus erythematosus.

Authors:  A Doria; M Canova; M Tonon; M Zen; E Rampudda; N Bassi; F Atzeni; S Zampieri; A Ghirardello
Journal:  Autoimmun Rev       Date:  2008-08-12       Impact factor: 9.754

8.  A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.

Authors:  Minoru Hasegawa; Yukiyo Matsushita; Mayuka Horikawa; Kiyoshi Higashi; Yoshitaka Tomigahara; Hideo Kaneko; Fumiaki Shirasaki; Manabu Fujimoto; Kazuhiko Takehara; Shinichi Sato
Journal:  Arthritis Rheum       Date:  2009-11

Review 9.  Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept.

Authors:  Ugo Fiocco; Paolo Sfriso; Francesca Oliviero; Elisa Pagnin; Elena Scagliori; Carla Campana; Serena Dainese; Luisella Cozzi; Leonardo Punzi
Journal:  Autoimmun Rev       Date:  2008-08-15       Impact factor: 9.754

10.  Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.

Authors:  Patrizia Fuschiotti; Thomas A Medsger; Penelope A Morel
Journal:  Arthritis Rheum       Date:  2009-04
View more
  3 in total

Review 1.  Nailfold capillaroscopy: tips and challenges.

Authors:  Yasser El Miedany; Sherif Ismail; Mary Wadie; Mohammed Hassan
Journal:  Clin Rheumatol       Date:  2022-08-30       Impact factor: 3.650

2.  Cutting-edge issues in autoimmunity and allergy of the digestive system.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2012-06       Impact factor: 8.667

Review 3.  T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.

Authors:  Isabel Almeida; Sara Vieira Silva; Ana Raquel Fonseca; Ivone Silva; Carlos Vasconcelos; Margarida Lima
Journal:  Clin Rev Allergy Immunol       Date:  2015-12       Impact factor: 8.667
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.